HealthFDA approved lung cancer drug created by Mirati to cost $19,750 for 180 tabletsEditorDecember 13, 2022 by EditorDecember 13, 20220356 The US Food and Drug Administration has approved Mirati Therapeutics Inc’s lung cancer drug Adagrasib, according to the company, sending shares of the company up more than 8% in extended trading following the announcement. Mirati’s...
